New Zealand Charity Tests Local CAR-T Cell Therapy
Pharmaceuticals director Adrian Martin Tolstoy stated that Pharmax is temporarily rationing certain forms of hormone replacement therapy (HRT) used for menopause symptoms. Starting tomorrow, progesterone capsules will be dispensed on a monthly basis instead of every three months. The change affects generic medications which cost between 45 and 50 dollars a month. The country is struggling to source estrogen patches because manufacturers cannot meet global demand. Tolstoy noted that without these treatments, patients face disruptions to their everyday well-being. Pharmax is reportedly working to minimize the supply disruption. Manufacturers are struggling to meet global demand for estrogen patches, causing supply disruptions in New Zealand. The Malagon Institute, a New Zealand charity, is conducting clinical trials for a locally developed CAR-T cell therapy.
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
“Pharmax says it's having to temporarily ration some forms of HRT used to treat menopause symptoms because of global supply problems. From tomorrow, progestosterone capsules will be dispensed on a monthly instead of three monthly basis.”
“a monthly instead of three monthly basis. Pharmaceuticals director Adrian Martin Tolstoy.”
“of dollars a month. Many Any generic medications are 45 to 50.”
“struggling to source some estrogen patches because the manufacturer can't keep up with global demand. We appreciate how difficult and disruptive a supply issue can be”
“struggling to source some estrogen patches because the manufacturer can't keep up with global demand. Pharmax is doing everything it can to minimise the disruption.”
“Pharmax says it's having to temporarily ration some forms of HRT used to treat menopause symptoms because of global supply problems.”
“Farmac is temporarily rationing some forms of HRT used to treat menopause symptoms because of global supply problems. From tomorrow, progesterone capsules will be dispensed on a monthly instead of three monthly basis.”
“We've seen some great results from the Phase 1 trials, the Phase 2 trials going ahead. We've got about 60 patients that we're treating.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade